Abstract: In space-time joint adaptive anti-jamming implementation, such as MVDR, LCMV, etc., the inversion of the covariance matrix is a critical step and the computation load is large. In this paper ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

DNA Ginkgo Bioworks Holdings, Inc.

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

RXRX Stock jumps after JPMorgan upgrade and trial data boost, fueling investor optimism in Recursion’s AI drug discovery ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Any time you tap, swipe or dip a credit or debit card at checkout or enter your card number online, you ...

I played these 25 cards the most and built so many decks around them — or at least dreamed how they might function in the ...

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...